Hepatic Insufficiency Global Clinical Trials Review, H1, 2015

Date: April 27, 2015
Pages: 75
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: HE8C0128021EN
Leaflet:

Download PDF Leaflet

Hepatic Insufficiency Global Clinical Trials Review, H1, 2015
Hepatic Insufficiency Global Clinical Trials Review, H1, 2015

SUMMARY

GlobalData's clinical trial report, “Hepatic Insufficiency Global Clinical Trials Review, H1, 2015' provides data on the Hepatic Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Insufficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatic Insufficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
REASONS TO BUY
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Hepatic Insufficiency
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Hepatic Insufficiency
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Hepatic Insufficiency Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Puma Biotechnology, Inc.
Clinical Trial Overview of Puma Biotechnology, Inc.
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
C. H. Boehringer Sohn AG & Co. KG
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Astellas Pharma Europe Ltd.
Clinical Trial Overview of Astellas Pharma Europe Ltd.
Clinical Trial Overview of Top Institutes / Government
Copenhagen University Hospital Gentofte
Clinical Trial Overview of Copenhagen University Hospital Gentofte
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
Aarhus University
Clinical Trial Overview of Aarhus University
Donau-Universitat Krems
Clinical Trial Overview of Donau-Universitat Krems
Huashan Hospital
Clinical Trial Overview of Huashan Hospital
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
McGill University Health Center
Clinical Trial Overview of McGill University Health Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Region, 2015
Hepatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015
Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2015
Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015
Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015
Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015
Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015
Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015
Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Phase, 2015
Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015
Hepatic Insufficiency Therapeutics, Global, Terminated Clinical Trials, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Puma Biotechnology, Inc., 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Europe Ltd., 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Copenhagen University Hospital Gentofte, 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Donau-Universitat Krems, 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Huashan Hospital, 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2015

LIST OF FIGURES

Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Region (%), 2015
Hepatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015
Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015
Hepatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015
Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015
Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015
Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015
Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015
Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015
Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015
Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015
GlobalData Methodology
Skip to top


Hepatitis B Global Clinical Trials Review, Q2, 2011 US$ 1,000.00 Jun, 2011 · 81 pages
Hepatitis C Global Clinical Trials Review, Q2, 2011 US$ 1,000.00 Jun, 2011 · 84 pages
Hepatitis A Global Clinical Trials Review, Q2, 2011 US$ 1,000.00 Jun, 2011 · 46 pages
Hepatitis B Global Clinical Trials Review, H2, 2014 US$ 2,500.00 Nov, 2014 · 134 pages
Hepatitis A Global Clinical Trials Review, H1, 2013 US$ 2,500.00 Jun, 2013 · 93 pages

Ask Your Question

Hepatic Insufficiency Global Clinical Trials Review, H1, 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: